Sulfonylurea KATPBlockade in Type II Diabetes and Preconditioning in Cardiovascular Disease
Authors:
- 1 November 1996
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 94 (9) , 2297-2301
Abstract
I n the early 1970s, the UGDP assessed the efficacy of oral hypoglycemic treatment in comparison with insulin and diet alone in the prevention of vascular complications. The surprising finding was the appearance of a significantly higher cardiovascular mortality in patients on oral hypoglycemic agents (sulfonylureas) compared with those on diet alone. Nonetheless, these agents are used extensively because, one suspects, of a lack of a plausible mechanism for the UGDP study results. In 1983, the KATP was discovered and was demonstrated to be sensitive to the sulfonylurea class of drugs; ie, these agents block the opening of this channel. In 1986, the phenomenon of ischemic preconditioning was discovered, which demonstrated the unique ability of a sublethal period of ischemia (angina) to protect the heart from a subsequent lethal ischemic insult. In the 1990s, it became clear that one of the probable mechanisms through which this preconditioning phenomenon worked was via the opening of the KATP. New discoveries often shed light on old mysteries, and this may be the case with the sulfonylurea class of oral hypoglycemic agents. Therefore, it is timely to rethink the seemingly paradoxical result of the UGDP study. In 1942, Janbon et al1 found that sulfonamide derivatives used to treat typhoid fever caused hypoglycemia, which led to the development of a new treatment for NIDDM. Diabetes is a significant problem worldwide. For example, six million people in the United States have NIDDM (85% of all diabetics) and are eligible for treatment with these drugs. The National Disease and Therapeutic Index estimates that 54% of physician visits by these patients included a prescription for oral hypoglycemic agents and that in 1994 there were 2.5 million patient-years of treatment, accounting for $500 million in sales in the United States alone. Recent insight into the …Keywords
This publication has 50 references indexed in Scilit:
- Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea ReceptorScience, 1995
- Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemiaCardiovascular Research, 1994
- Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injuryJACC, 1994
- Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injuryCardiovascular Research, 1993
- Ischemic preconditioningTrends in Cardiovascular Medicine, 1992
- Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: A prospective studyJACC, 1992
- Myocardial adenosine formation during hypoxia: Effects of ecto-5′-nucleotidase inhibitionJournal of Molecular and Cellular Cardiology, 1992
- Hypoxic Dilation of Coronary Arteries Is Mediated by ATP-Sensitive Potassium ChannelsScience, 1990
- Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarctionAmerican Heart Journal, 1990
- Adaptation to Exercise in Angina PectorisCirculation, 1966